GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Carlsmed CARL · USD

Health Care · US listing · 🇺🇸 United States

Compare

16.05

+10.54%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$54.3m

FY2023FY2024

Net income

−$49.7m

FY2023FY2024

Free cash flow

−$51.1m

FY2023FY2024

Shareholders' equity

$25.6m

FY2023FY2024

Income statement

Fiscal years

FY2024FY2023
Revenue$54.3m$27.6m
Gross profit$20.0m$9.9m
Research and development$14.3m$7.4m
Operating income−$48.2m−$37.2m
Net income−$49.7m−$37.8m
Diluted earnings per share-1.87-1.43

Balance sheet

At each fiscal year end

FY2024FY2023
Total assets$51.8m$14.0m
Cash and short-term investments$40.1m$7.2m
Total liabilities$26.2m$16.8m
Debt$15.4m$9.3m
Shareholders' equity$25.6m−$2.8m
Shares outstanding27m27m

Cash flow

Fiscal years

FY2024FY2023
Cash from operations−$50.9m−$35.0m
Capital spending−$180,000−$135,000
Free cash flow−$51.1m−$35.1m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Mar 2024
Revenue$13.1m$12.1m$10.2m$27.2m$5.1m
Gross profit$9.9m$8.9m$7.6m$20.0m$3.7m
Operating income−$9.0m−$6.5m−$5.7m−$24.1m−$5.3m
Net income−$8.5m−$6.8m−$6.3m−$24.8m−$5.4m
Diluted earnings per share-0.40-0.26-0.24-0.94-0.21
Total assets$134.9m$53.3m$57.8m——
Cash and short-term investments$115.4m$33.5m$43.4m——
Debt$15.4m$15.4m$15.4m——
Shareholders' equity$106.7m$25.7m$32.1m——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.6%———

Share price return

Finished calendar years

2025
Return-13%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.